This team is a realization of a concept envisioned by late Apple co-founder Steve Jobs, developing sensors with ability to constantly monitor sugar levels in a patient's blood circulation. The team is using smart watches to monitor important changes, like heart rate, oxygen levels, and blood glucose, which was envisioned by Steve Jobs. The initiative pits Apple against a technical challenge that has thwarted researchers for years-plus competitors including Alphabet's Verily-in a push to create a device that frees diabetics from finger-prick blood glucose readings. These included Anne Shelchuk, formerly of ultrasound company Zonare, Craig Slyfield, an expert on human bone 3D visualisation, and perhaps most interestingly in the wearables field, Jay Mung, who previously researched sensor algorithms for Medtronic's continuous glucose monitoring system.
Apple is developing optical sensors, which involves shining a light through the skin to measure indications of glucose, the report noted.
It would also be a game changer for Apple Watch and Apple itself. But, they've all failed at achieving a breakthrough in tracking the sugar levels by just placing the device against the skin.
It is now believed that the project is so far ahead that the team is already running trials of the sensors at clinical sites in the San Francisco Bay Area.
This is significant because Apple would require substantial levels of regulatory clearance to market a device with that kind of ability. Rumors of Apple's work on advanced healthcare initiatives like diabetes management aren't new.
Those hires, reported early past year, sparked speculation that Apple may indeed be working on such a product.
The company's glucose team is said to report to the company's senior VP of hardware technologies, Johny Srouji.
According to CNBC, Apple did not respond to requests for comment.
An Apple Watch for diabetics would also make AAPL's wearable a must-have for hundreds of millions of people.
"There is a cemetery full of efforts" to measure glucose levels in a non-invasive way, DexCom chief executive Terrance Gregg told Reuters in 2014. The tech would use non-invasive sensors to monitor the body to detect diabetes in people, allowing timely treatment.